amantadine has been researched along with ketamine in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (11.54) | 18.7374 |
1990's | 4 (15.38) | 18.2507 |
2000's | 13 (50.00) | 29.6817 |
2010's | 4 (15.38) | 24.3611 |
2020's | 2 (7.69) | 2.80 |
Authors | Studies |
---|---|
Hecht, P; Kornhuber, J; Koutsilieri, E; Kroemer, RT; Liedl, KR; Riederer, P | 1 |
Topliss, JG; Yoshida, F | 1 |
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
Almonte, A; Balster, R; Barber, J; Dravid, SM; Erreger, K; French, A; Le, P; Lyuboslavsky, P; Mosely, C; Murray, E; Murray, TF; Nicholson, K; Traynelis, SF; Yuan, H | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brea, JM; Companys-Alemany, J; Griñán-Ferré, C; Johnson, JW; Kurnikova, MG; Loza, MI; Pallàs, M; Patel, DS; Pérez, B; Phillips, MB; Soto, D; Sureda, FX; Turcu, AL; Vázquez, S | 1 |
Bonezzi, C; Mapelli, A; Pagani, I | 1 |
DeDonato, A; Lucca, GP; Montanari, C | 1 |
Carbonera, D; Domenichini, E; Pagnin, A; Scherini, A | 1 |
Feuerstein, TJ | 1 |
Krishtal, OA; Panchenko, VA; Parsons, CG; Pinchenko, VO; Tsyndrenko, AY | 1 |
Karge, E; Kerst, S; Klinger, W; Lupp, A; Quack, G | 1 |
Krisztin-Péva, B; Mihály, A; Szakács, R; Weiczner, R; Zádor, E; Zádor, Z | 1 |
Block, F; Habermeyer, B | 1 |
Amlie-Lefond, CM; Chusid, MJ; Ghanayem, NS; Hoffman, GM; Rupprecht, CE; Schwabe, MJ; Tieves, KS; Willoughby, RE | 1 |
Jackson, AC | 2 |
Inomata, S; Kakiuchi, Y; Kohda, Y; Miyabe, M; Ohara, Y; Osaka, Y; Sukegawa, I; Toyooka, H | 1 |
Howland, RH | 1 |
Maeng, S; Zarate, CA | 1 |
David, D; Garcia, C; Guarda, DC; Rubin, J; Rupprecht, CE; Stamler, A; Willoughby, RE; Zohar, Z | 1 |
Mamie, C | 1 |
Fouilhé Sam-Laï, N; Jouanjus, E; Lapeyre-Mestre, M; Revol, B | 1 |
5 review(s) available for amantadine and ketamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Glutamate antagonists for treatment of neuropathic pain].
Topics: Amantadine; Animals; Disease Models, Animal; Excitatory Amino Acid Antagonists; Humans; Ketamine; Memantine; Neuralgia | 2003 |
Glutamate-modulating drugs & the treatment of mental disorders.
Topics: Acamprosate; Amantadine; Cycloserine; Glutamic Acid; Humans; Ketamine; Lamotrigine; Memantine; Mental Disorders; Psychotropic Drugs; Riluzole; Taurine; Triazines | 2007 |
The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects.
Topics: Amantadine; Depressive Disorder, Major; Dopamine Agents; Excitatory Amino Acid Antagonists; Humans; Ketamine; Memantine; Mood Disorders; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate | 2007 |
[Prevention of postoperative hyperalgesia].
Topics: Amantadine; Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Hyperalgesia; Ketamine; Magnesium Compounds; Pain Management; Pain, Postoperative; Receptors, N-Methyl-D-Aspartate; Risk Assessment | 2012 |
2 trial(s) available for amantadine and ketamine
Article | Year |
---|---|
Ketamine induction and amantadine.
Topics: Adult; Amantadine; Anesthesia, General; Blood Pressure; Clinical Trials as Topic; Diazepam; Female; Humans; Ketamine; Male; Middle Aged; Psychophysiology; Respiration | 1975 |
Sequential trial upon the awakening effect of amantadine after ketamine anaesthesia.
Topics: Adult; Amantadine; Anesthesia, Intravenous; Anesthetics, Dissociative; Clinical Trials as Topic; Humans; Injections, Intravenous; Ketamine; Male; Middle Aged; Placebos; Postoperative Care; Wakefulness | 1972 |
19 other study(ies) available for amantadine and ketamine
Article | Year |
---|---|
Quantitative analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding site.
Topics: Binding Sites; Excitatory Amino Acid Antagonists; Humans; Molecular Structure; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 1998 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.
Topics: Animals; Cell Line; Dizocilpine Maleate; Electrophysiology; Excitatory Amino Acid Antagonists; Humans; Hydrogen-Ion Concentration; Ion Channel Gating; Ion Channels; Male; Mice; Mice, Inbred C57BL; Patch-Clamp Techniques; Protons; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins; Stereoisomerism; Xenopus laevis | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Caenorhabditis elegans; Disease Models, Animal; Memantine; Mice; Receptors, N-Methyl-D-Aspartate | 2022 |
[Action of amantadine on arousal from balanced diazepam-ketamine anesthesia in patients undergoing angiographic examinations].
Topics: Amantadine; Anesthesia, General; Angiography; Aortography; Diazepam; Humans; Ketamine | 1976 |
[Ketamine inhibits n-methyl-d-aspartate (NMDA) receptor mediated acetylcholine release from rabbit caudate nucleus slices].
Topics: Acetylcholine; Action Potentials; Amantadine; Animals; Caudate Nucleus; Choline; Dizocilpine Maleate; In Vitro Techniques; Ketamine; Memantine; Rabbits; Receptors, N-Methyl-D-Aspartate; Valine | 1994 |
Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine.
Topics: Amantadine; Animals; Dose-Response Relationship, Drug; Hippocampus; Ketamine; Memantine; Membrane Potentials; N-Methylaspartate; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1996 |
Investigation on possible antioxidative properties of the NMDA-receptor antagonists ketamine, memantine, and amantadine in comparison to nicanartine in vitro.
Topics: 7-Alkoxycoumarin O-Dealkylase; Amantadine; Animals; Antioxidants; Antiparkinson Agents; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Hydrogen Peroxide; Ketamine; Lipid Peroxidation; Male; Memantine; Microsomes, Liver; Pyridines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Thiobarbituric Acid Reactive Substances | 1998 |
Non-competitive NMDA receptor antagonists moderate seizure-induced c-fos expression in the rat cerebral cortex.
Topics: 4-Aminopyridine; Amantadine; Animals; Behavior, Animal; Cerebral Cortex; Dizocilpine Maleate; Dopamine Agents; Epilepsy; Excitatory Amino Acid Antagonists; Gene Expression; Hippocampus; Immunohistochemistry; Ketamine; Male; Potassium Channel Blockers; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; RNA, Messenger | 2003 |
Survival after treatment of rabies with induction of coma.
Topics: Adolescent; Amantadine; Anesthetics; Animals; Antiviral Agents; Athetosis; Benzodiazepines; Bites and Stings; Chiroptera; Chorea; Coma; Dysarthria; Female; Gait Disorders, Neurologic; Humans; Ketamine; Midazolam; Rabies; Rabies virus; Ribavirin | 2005 |
Recovery from rabies.
Topics: Amantadine; Anesthetics; Animals; Antiviral Agents; Bites and Stings; Chiroptera; Coma; Excitatory Amino Acid Antagonists; Humans; Ketamine; Midazolam; Rabies; Rabies Vaccines; Survivors | 2005 |
Combined therapy with clonidine and amantadine may act in two stages of glutamate-mediated neuropathic pain caused by a needle puncture in an upper extremity.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Analgesics, Non-Narcotic; Calcium Channel Blockers; Catheterization, Peripheral; Clonidine; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Ketamine; Median Nerve; Pain; Peripheral Nervous System Diseases; Receptors, N-Methyl-D-Aspartate | 2005 |
Applying the Milwaukee protocol to treat canine rabies in Equatorial Guinea.
Topics: Amantadine; Anesthetics, Dissociative; Animals; Antiviral Agents; Child, Preschool; Combined Modality Therapy; Dogs; Drug Therapy, Combination; Equatorial Guinea; Fatal Outcome; Humans; Ketamine; Male; Midazolam; Rabies; Rabies virus; Ribavirin; Treatment Outcome; Ubiquinone | 2009 |
Therapy of rabies encephalitis.
Topics: Adolescent; Amantadine; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Chiroptera; Clinical Protocols; Combined Modality Therapy; Deep Sedation; Electroencephalography; Encephalitis, Viral; Excitatory Amino Acid Antagonists; Female; Humans; Ketamine; Midazolam; Phenobarbital; Rabies; Rabies virus; Ribavirin | 2009 |
Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database.
Topics: Amantadine; Analgesics; Bayes Theorem; Dextromethorphan; Humans; Ketamine; Memantine; Pharmacovigilance; Receptors, N-Methyl-D-Aspartate; Substance-Related Disorders; World Health Organization | 2022 |